METHOD FOR TREATING THE CASES OF KERATOLEUKOMA AFTER VIRAL KERATITIS OCCURRED

medicine. SUBSTANCE: method involves carrying out phototherapeutic keratectomy in the cornea ablation zone of 9 mm diameter. Treatment for preventing recidivation is applied during the first day after the operation using Poludan solution administered as subconjunctival injections 1-2 times a week at...

Full description

Saved in:
Bibliographic Details
Main Authors KASPAROV A.A, POLUNIN G.S, KURENKOV V.V, KASPAROVA E.A
Format Patent
LanguageEnglish
Russian
Published 20.01.2001
Edition7
Subjects
BANDAGES, DRESSINGS OR ABSORBENT PADS
DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF,TUBULAR STRUCTURES OF THE BODY, E.G. STENTS
FILTERS IMPLANTABLE INTO BLOOD VESSELS
FIRST-AID KITS
FOMENTATION
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES
PROSTHESES
TREATMENT OR PROTECTION OF EYES OR EARS
Online AccessGet full text

Cover

More Information
Summary:medicine. SUBSTANCE: method involves carrying out phototherapeutic keratectomy in the cornea ablation zone of 9 mm diameter. Treatment for preventing recidivation is applied during the first day after the operation using Poludan solution administered as subconjunctival injections 1-2 times a week at a dose of 200 units in 0.5 ml of physiological salt solution and Poludan solution administered as instillations at a dose of 200 units in 2.0 ml of physiological salt solution. The solution is introduced into the conjunctival sack 2-4 times a day in the amount of 1-2 drops. EFFECT: avoided manifestations of astigmatism.
Bibliography:Application Number: RU19980116904